These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27374605)

  • 1. Frequency of Methamphetamine Use as a Major Contributor Toward the Severity of Cardiomyopathy in Adults ≤50 Years.
    Neeki MM; Kulczycki M; Toy J; Dong F; Lee C; Borger R; Adigopula S
    Am J Cardiol; 2016 Aug; 118(4):585-9. PubMed ID: 27374605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse.
    Ito H; Yeo KK; Wijetunga M; Seto TB; Tay K; Schatz IJ
    Clin Cardiol; 2009 Jun; 32(6):E18-22. PubMed ID: 19330818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
    Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
    Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction.
    Reddy PK; Chau E; Patel SV; Yang K; Ng TM; Elkayam U
    Am J Cardiol; 2021 Sep; 154():86-91. PubMed ID: 34233837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.
    Goland S; Bitar F; Modi K; Safirstein J; Ro A; Mirocha J; Khatri N; Elkayam U
    J Card Fail; 2011 May; 17(5):426-30. PubMed ID: 21549301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction.
    Alla F; Al-Hindi AY; Lee CR; Schwartz TA; Patterson JH; Adams KF
    Am Heart J; 2007 Jun; 153(6):1074-80. PubMed ID: 17540212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction.
    Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of methamphetamine use and cardiomyopathy in young patients.
    Yeo KK; Wijetunga M; Ito H; Efird JT; Tay K; Seto TB; Alimineti K; Kimata C; Schatz IJ
    Am J Med; 2007 Feb; 120(2):165-71. PubMed ID: 17275458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
    Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE
    Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples.
    Mau MK; Asao K; Efird J; Saito E; Ratner R; Hafi M; Seto T
    Vasc Health Risk Manag; 2009; 5(1):45-52. PubMed ID: 19436660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study.
    Hedberg P; Lönnberg I; Jonason T; Nilsson G; Pehrsson K; Ringqvist I
    Eur Heart J; 2001 Apr; 22(8):676-83. PubMed ID: 11286525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathy in Patients With Acute Ischemic Stroke and Methamphetamine Use: Relevance for Cardioembolic Stroke and Outcome.
    Lee SJ; Liu S; Blackwill H; Stradling D; Shafie M; Yu W
    J Am Heart Assoc; 2024 Apr; 13(7):e033667. PubMed ID: 38533970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
    Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents.
    Cui X; Zhou J; Jin X; Zhou J; Fu M; Hu K; Sun A; Ge J
    Int J Cardiol; 2017 Jan; 227():820-825. PubMed ID: 27836303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.